The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
Author:
Funder
Multiple Sclerosis Society of Canada
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Link
https://link.springer.com/content/pdf/10.1007/s00415-020-10160-7.pdf
Reference37 articles.
1. Centers for Disease Control. Coronavirus. https://www.cdc.gov/coronavirus/types.html. Accessed May 15, 2020.
2. Mao L, Wang M, Hu Y et al (2020) Neurologic manifestations of hospitalized patients with coronavirua disease 2019 in Wuhan, China. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1127
3. Herman C, Mayer K, Sarwal A (2020) Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. https://doi.org/10.1212/WNL
4. Borrielloa G, Iannielloc A (2020) COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach. Mult Scler Relat Disord. https://doi.org/10.1016/j.msard.2020.102165
5. Barzegar M, Mirmosayyeb O, Nehzat N et al (2020) COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000000753
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of a Day Wellness Program for People With Multiple Sclerosis Before and During the COVID-19 Pandemic;International Journal of MS Care;2024-08-26
2. Depression and anxiety in multiple sclerosis. Review of a fatal combination;Journal of Neural Transmission;2024-06-13
3. The relationship between healthcare access and change in health-related quality-of-life among the general population of five countries during the COVID-19 pandemic;Quality of Life Research;2024-06-11
4. Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study protocol;BMJ Open;2024-02
5. Era of COVID-19 in Multiple Sclerosis Care;Neurologic Clinics;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3